In humans, a condition characterized by xerophthalmia and xerostomia that results from lymphocyte-mediated destruction of exocrine glands is termed Sjögren's syndrome (SS). The syndrome may be a primary autoimmune disease or part of another immunologically mediated connective-tissue disorder. ▶ Sjögren's syndrome may be diagnosed on the basis of a combination of xerophthalmia, xerostomia, and lymphocytic infiltration of salivary glands. ▶ Treatment for SS is aimed at alleviating clinical signs. Pharmacologic immunosuppression does not alleviate xerophthalmia or xerostomia.
|Original language||English (US)|
|Number of pages||7|
|Journal||Journal of the American Veterinary Medical Association|
|State||Published - Jan 1 2001|
ASJC Scopus subject areas